nach oben

AIDS and Behavior

Erschienen in:

01.09.2013 | Substantive Review

Conditional Economic Incentives to Improve HIV Treatment Adherence: Literature Review and Theoretical Considerations

verfasst von: Omar Galárraga, Becky L. Genberg, Rosemarie A. Martin, M. Barton Laws, Ira B. Wilson

Erschienen in: AIDS and Behavior | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

We present selected theoretical issues regarding conditional economic incentives (CEI) for HIV treatment adherence. High HIV treatment adherence is essential not only to improve individual health for persons living with HIV, but also to reduce transmission. The incentives literature spans several decades and various disciplines, thus we selectively point out useful concepts from economics, psychology and HIV clinical practice to elucidate the complex interaction between socio-economic issues, psychological perspectives and optimal treatment adherence. Appropriately-implemented CEI can help patients improve their adherence to HIV treatment in the short-term, while the incentives are in place. However, more research is needed to uncover mechanisms that can increase habit formation or maintenance effects in the longer-term. We suggest some potentially fruitful avenues for future research in this area, including the use of concepts from self-determination theory. This general framework may have implications for related research among disadvantaged communities with high rates of HIV/AIDS infection.

Hogg RS, Heath KV, Yip B, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA. 1998;279(6):450–4.PubMedCrossRef

Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS clinical trials group 320 study team. N Engl J Med. 1997;337(11):725–33.PubMedCrossRef

Hirsch M, Steigbigel R, Staszewski S, et al. A randomized, controlled trial of indinavir, zidovudine, and lamivudine in adults with advanced human immunodeficiency virus type 1 infection and prior antiretroviral therapy. J Infect Dis. 1999;180(3):659–65.PubMedCrossRef

Bangsberg DR, Perry S, Charlebois ED, et al. Non-adherence to highly active antiretroviral therapy predicts progression to AIDS. AIDS. 2001;15(9):1181–3.PubMedCrossRef

Simoni JM, Amico KR, Pearson CR, Malow R. Strategies for promoting adherence to antiretroviral therapy: a review of the literature. Curr Infect Dis Rep. 2008;10(6):515–21.PubMedCrossRef

Haug NA, Sorensen JL, Gruber VA, Lollo N, Roth G. HAART adherence strategies for methadone clients who are HIV-positive: a treatment manual for implementing contingency management and medication coaching. Behav Modif. 2006;30(6):752–81.PubMedCrossRef

Haug NA, Sorensen JL. Contingency management interventions for HIV-related behaviors. Curr HIV/AIDS Rep. 2006;3(4):154–9.PubMedCrossRef

Rosen MI, Dieckhaus K, McMahon TJ, et al. Improved adherence with contingency management. AIDS Patient Care STDs. 2007;21(1):30–40.PubMedCrossRef

Sorensen JL, Haug NA, Delucchi KL, et al. Voucher reinforcement improves medication adherence in HIV-positive methadone patients: a randomized trial. Drug Alcohol Depend. 2007;88(1):54–63.PubMedCrossRef

10.

Petry NM, Rash CJ, Byrne S, Ashraf S, White WB. Financial reinforcers for improving medication adherence: findings from a meta-analysis. Am J Med. 2012;125(9):888–96.PubMedCrossRef

11.

Defulio A, Silverman K. The use of incentives to reinforce medication adherence. Prev Med. 2012;. doi:10.1016/j.ypmed.2012.04.017.

12.

Griffith JD, Rowan-Szal GA, Roark RR, Simpson DD. Contingency management in outpatient methadone treatment: a meta-analysis. Drug Alcohol Depend. 2000;58(2-Jan):55–66.PubMedCrossRef

13.

Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006;101(2):192–203.PubMedCrossRef

14.

Prendergast M, Podus D, Finney J, Greenwell L, Roll J. Contingency management for treatment of substance use disorders: a meta-analysis. J Subst Abuse Treat. 2006;101(11):1546–60.

15.

Dutra L, Stathopoulou G, Basden SL, Leyro TM, Powers MB, Otto MW. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179–87.PubMedCrossRef

16.

Higgins ST, Silverman K, Heil SH, editors. Contingency management in substance abuse treatment. New York: Guilford Press; 2008.

17.

Dallery J, Meredith SE, Budney AJ. Contingency management in substance abuse treatment. In: Walters ST, Rotgers F, editors. Treating substance abuse: theory and technique. 3rd ed. New York: Guilford Press; 2012.

18.

Giuffrida A, Torgerson DJ. Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997;315(7110):703–7.PubMedCrossRef

19.

Fiszbein A, Schady N, Ferreira FHG. Conditional cash transfers: reducing present and future poverty [Chapter 2: Economic Rationale]. Washington D.C.: World Bank; 2009.CrossRef

20.

Loewenstein G, Brennan T, Volpp KG. Asymmetric paternalism to improve health behaviors. JAMA. 2007;298(20):2415–7.PubMedCrossRef

21.

Rabin M. Psychology and economics. J Econ Lit. 1998;36(1):11–46.

22.

DellaVigna S. Psychology and economics: evidence from the field. J Econ Lit. 2009;47(2):315–72.CrossRef

23.

Frederick S, Loewenstein G, O’Donoghue T. Time discounting and time preference: a critical review. J Econ Lit. 2002;40(2):351–401.CrossRef

24.

Laibson D. Golden eggs and hyperbolic discounting. Q J Econ. 1997;112(2):443–77.CrossRef

25.

Zimbardo PG, Boyd JN. Putting time in perspective: a valid, reliable individual-differences metric. J Pers Soc Psychol. 1999;77(6):1271–88.CrossRef

26.

Boyd JN, Zimbardo PG. Time perspective, health, and risk taking. In: Strathman A, Joireman J, editors. Understanding behavior in the context of time: theory, research, and application. Mahwah: Lawrence Erlbaum Associates; 2005.

27.

Murphy JG, MacKillop J, Vuchinich RE, Tucker JA. The behavioral economics of substance abuse. In: Walters ST, Rotgers F, editors. Treating substance abuse: theory and technique. 3rd ed. New York: Guilford; 2012.

28.

Marshall A. Principles of economics. London and New York: Macmillan; 1890.

29.

Strecher VJ, Rosenstock IM. The health belief model. In: Glanz K, Lewis FM, editors. Health behavior and health education: theory, research and practice. San Francisco: Jossey-Bass; 1997.

30.

Deci EL, Ryan RM. A motivational approach to self: integration in personality. Nebr Symp Motiv. 1990;38:237–88.PubMed

31.

Deci EL, Koestner R, Ryan RM. A meta-analytic review of experiments examining the effects of extrinsic rewards on intrinsic motivation. Psychol Bull. 1999;125(6):627–68. discussion 692-700.PubMedCrossRef

32.

Ryan RM, Deci EL. Intrinsic and extrinsic motivations: classic definitions and new directions. Contemp Educ Psychol. 2000;25(1):54–67.PubMedCrossRef

33.

Deci EL, Ryan RM. The “what” and “why” of goal pursuits: human needs and the self-determination of behavior. Psychol Inq. 2000;11(4):227–68.CrossRef

34.

Deci EL, Ryan RM. Self-determination theory: a macrotheory of human motivation, development, and health. Can Psychol. 2008;49(3):182–5.CrossRef

35.

Rigby CS, Deci EL, Patrick BC, Ryan RM. Beyond the intrinsic extrinsic dichotomy—self-determination in motivation and learning. Motiv Emotion. 1992;16(3):165–85.CrossRef

36.

Cameron J. Negative effects of reward on intrinsic motivation—A limited phenomenon: comment on Deci, Koestner, and Ryan (2001). Rev Educ Res. 2001;71(1):29–42.CrossRef

37.

Cameron J, Banko KM, Pierce WD. Pervasive negative effects of rewards on intrinsic motivation: the myth continues. Behav Analyst. 2001;24(1):1–44.

38.

Pierce WD, Cameron J, Banko KM, So S. Positive effects of rewards and performance standards on intrinsic motivation. Psychol Rec. 2003;53:561–79.

39.

Miller WR, Rose GS. Toward a theory of motivational interviewing. Am Psychol. 2009;64(6):527–37.PubMedCrossRef

40.

Williams GC, Rodin GC, Ryan RM, Grolnick WS, Deci EL. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol. 1998;17(3):269–76.PubMedCrossRef

41.

Ryan RM, Deci EL. Self-regulation and the problem of human autonomy: does psychology need choice, self-determination, and will? J Pers. 2006;74(6):1557–85.PubMedCrossRef

42.

DiIorio C, McCarty F, Resnicow K, et al. Using motivational interviewing to promote adherence to antiretroviral medications: a randomized controlled study. AIDS Care. 2008;20(3):273–83.PubMedCrossRef

43.

Bandura A. Social learning theory. Englewood Cliffs: Prentice Hall; 1977.

44.

Azjen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs: Prentice-Hall; 1980.

45.

Prochaska JO, Norcross JC, DiClemente CC. Changing for good: the revolutionary program that explains the six stages of change and teaches you how to free yourself from bad habits. New York: W. Morrow; 1994.

46.

Prochaska JO, DiClemente CC. The transtheoretical approach: crossing traditional boundaries of therapy. Homewood: Dow Jones-Irwin; 1984.

47.

Roozen HG, Boulogne JJ, van Tulder MW, van den Brink W, De Jong CA, Kerkhof AJ. A systematic review of the effectiveness of the community reinforcement approach in alcohol, cocaine and opioid addiction. Drug Alcohol Depend. 2004;74(1):1–13.PubMedCrossRef

48.

Link BG, Phelan J. Social conditions as fundamental causes of disease. J Health Soc Behav. 1995;Spec No:80-94.

49.

Farmer P. Social scientists and the new tuberculosis. Soc Sci Med. 1997;44:347–58.PubMedCrossRef

50.

Simoni JM, Huh D, Frick PA, et al. Peer support and pager messaging to promote antiretroviral modifying therapy in Seattle: a randomized controlled trial. J Acquir Immune Defic Syndr. 2009;52(4):465–73.PubMedCrossRef

51.

Simoni JM, Frick PA, Huang B. A longitudinal evaluation of a social support model of medication adherence among HIV-positive men and women on antiretroviral therapy. Health Psychol. 2006;25(1):74–81.PubMedCrossRef

52.

Koenig LJ, Pals SL, Bush T, Pratt Palmore M, Stratford D, Ellerbrock TV. Randomized controlled trial of an intervention to prevent adherence failure among HIV-infected patients initiating antiretroviral therapy. Health Psychol. 2008;27(2):159–69.PubMedCrossRef

53.

Deering KN, Shannon K, Sinclair H, Parsad D, Gilbert E, Tyndall MW. Piloting a peer-driven intervention model to increase access and adherence to antiretroviral therapy and HIV care among street-entrenched HIV-positive women in Vancouver. AIDS Patient Care STDs. 2009;23(8):603–9.PubMedCrossRef

54.

DiMatteo MR. Social support and patient adherence to medical treatment: a meta-analysis. Health Psychol. 2004;23(2):207–18.PubMedCrossRef

55.

Ware NC, Idoko J, Kaaya S, et al. Explaining adherence success in sub-Saharan Africa: an ethnographic study. PLoS Med. 2009;6(1):e11.PubMedCrossRef

56.

Bandura A. Human agency in social cognitive theory. Am Psychol. 1989;44(9):1175–84.PubMedCrossRef

57.

Fisher JD, Amico KR, Fisher WA, Harman JJ. The information-motivation-behavioral skills model of antiretroviral adherence and its applications. Curr HIV/AIDS Rep. 2008;5(4):193–203.PubMedCrossRef

58.

Fisher JD, Fisher WA, Amico KR, Harman JJ. An information-motivation-behavioral skills model of adherence to antiretroviral therapy. Health Psychol. 2006;25(4):462–73.PubMedCrossRef

59.

Bury M. Chronic illness as biographical disruption. Sociol Health Illn. 1982;4:167–82.PubMedCrossRef

60.

Charmaz K. Loss of self: a fundamental form of suffering in the chronically ill. Sociol Health Illn. 1983;5:168–95.PubMedCrossRef

61.

Aujoulat I, Marcolongo R, Bonadiman L, Deccache A. Reconsidering patient empowerment in chronic illness: a critique of models of self-efficacy and bodily control. Soc Sci Med. 2008;66:1228–39.PubMedCrossRef

62.

Baumgartner LM. The incorporation of the HIV/AIDS identity into the self over time. Qual Health Res. 2007;17:919–31.PubMedCrossRef

63.

Serpe RT. Stability and change in self: a structural symbolic interactionist explanation. Soc Psychol Q. 1987;50:44–55.CrossRef

64.

Auld MC. Disentangling the effects of morbidity and life expectancy on labor market outcomes. Health Econ. 2002;11(6):471–83.PubMedCrossRef

65.

Rigsby MO, Rosen MI, Beauvais JE, et al. Cue-dose training with monetary reinforcement: pilot study of an antiretroviral adherence intervention. J Gen Int Med. 2000;15(12):841–7.CrossRef

66.

Javanbakht M, Prosser P, Grimes T, Weinstein M, Farthing C. Efficacy of an individualized adherence support program with contingent reinforcement among nonadherent HIV-positive patients: results from a randomized trial. J Int Phys AIDS Care. 2006;5(4):143–50.

67.

Charness G, Gneezy U. Incentives to exercise. Econometrica. 2009;77(3):909–31.CrossRef

68.

Roll JM, Higgins ST, Badger GJ. An experimental comparison of three different schedules of reinforcement of drug abstinence using cigarette smoking as an exemplar. J Appl Behav Anal. 1996;29(4):495–504. quiz 504-5.PubMedCrossRef

69.

Deren S, Stephens R, Davis WR, Feucht TE, Tortu S. The impact of providing incentives for attendance at AIDS prevention sessions. Public Health Rep. 1994;109(4):548–54.PubMed

70.

Kamb ML, Rhodes F, Hoxworth T, et al. What about money? Effect of small monetary incentives on enrollment, retention, and motivation to change behaviour in an HIV/STD prevention counselling intervention. The Project RESPECT Study Group. Sex Transm Infect. 1998;74(4):253–5.PubMedCrossRef

71.

Simoni JM, Amico KR, Smith L, Nelson K. Antiretroviral adherence interventions: translating research findings to the real world clinic. Curr HIV/AIDS Rep. 2010;7(1):44–51.PubMedCrossRef

72.

McNairy ML, El-Sadr WM. The HIV care continuum: no partial credit given. AIDS. 2012;26(14):1735–8.PubMedCrossRef

73.

Benabou R, Tirole J. Intrinsic and extrinsic motivation. Rev Econ Stud. 2003;70(3):489–520.CrossRef

74.

Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505.PubMedCrossRef

Titel: Conditional Economic Incentives to Improve HIV Treatment Adherence: Literature Review and Theoretical Considerations
verfasst von: Omar Galárraga
Becky L. Genberg
Rosemarie A. Martin
M. Barton Laws
Ira B. Wilson
Publikationsdatum: 01.09.2013
Verlag: Springer US
Erschienen in: AIDS and Behavior / Ausgabe 7/2013
Print ISSN: 1090-7165
Elektronische ISSN: 1573-3254
DOI: https://doi.org/10.1007/s10461-013-0415-2

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2013

A Study of Financial Incentives to Reduce Plasma HIV RNA Among Patients in Care

Respondent Driven Sampling for HIV Biological and Behavioral Surveillance in Latin America and the Caribbean

HIV Testing and Intimate Partner Violence Among Non-Pregnant Women in 15 US States/Territories: Findings from Behavioral Risk Factor Surveillance System Survey Data

Patterns and Predictors of Multiple Sexual Partnerships Among Newly Arrived Latino Migrant Men

Dual HIV Risk: Receptive Syringe Sharing and Unprotected Sex Among HIV-Negative Injection Drug Users in New York City